All In MedTech

Device Trial Radar · NCT07300852

DSLT in Normal Tension Glaucoma (NTG) Asian Eyes

The Effectiveness of DSLT in Asian Normal Tension Glaucoma Patients

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jan 1, 2026

Primary completion

Jan 31, 2028

Study completion Mar 31, 2028

Sponsor

Lead sponsor
Ngoc Nguyen Inc.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Alcon Research
First posted
Dec 24, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the efficacy of direct selective laser trabeculoplasty (DSLT) or laser treatment in Asian patients with normal tension glaucoma. The main question it aims to answer is: Does the DSLT reduce intraocular pressure (IOP) and medication use in Asian NTG subjects? Participants will attend routine follow-up visits with their eye surgeon and glaucoma testing such as optical coherence tomography (OCT) imaging and visual field test(s) after the laser study treatment.

Conditions

  • Normal Tension Glaucoma (NTG)
  • Glaucoma
  • Open Angle Glaucoma (OAG)
  • Glaucoma, Open Angle

Interventions

  • Direct Selective Laser Trabeculoplasty (DSLT)Device

    Direct Selective Laser Trabeculoplasty (DSLT) is a non-contact laser procedure that delivers energy to the trabecular meshwork without the need for a gonioscopy lens. The BELKIN Vision Eagle device automatically aligns and applies laser pulses to lower intraocular pressure in subjects with normal tension glaucoma. All participants receive a single DSLT treatment followed by routine post-procedure evaluations including IOP checks, visual field testing, and OCT imaging.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Intraocular Pressure (IOP)Time frame: 12 months post procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ngoc Nguyen M.D.

    San Jose, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.